Amy Levin
Vermögen: 32 056 $ am 31.08.2026
Vermögen: 32 056 $ am 31.08.2026
Amy Levin currently works at Oncolytics Biotech, Inc., as Vice President-Clinical Operations from 2020.
Ms. Levin also formerly worked at Puma Biotechnology, Inc., as Senior Director-Clinical Operations from 2011 to 2020 and Janssen Oncology, Inc., as Director-Clinical Program Leader from 2007 to 2011.
Ms. Levin received her undergraduate degree from The University of Texas at Austin.
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
ONCOLYTICS BIOTECH INC. 0,03 % | 10.12.2025 | 38.253 ( 0,03 % ) | 32 056 $ | 31.08.2026 |
| Unternehmen | Position | Beginn |
|---|---|---|
| ONCOLYTICS BIOTECH INC. | Technik-/Wissenschafts-/F&E-Leiter | 01.09.2020 |
| Unternehmen | Position | Ende |
|---|---|---|
| PUMA BIOTECHNOLOGY, INC. | Technik-/Wissenschafts-/F&E-Leiter | 01.08.2020 |
Janssen Oncology, Inc.
Janssen Oncology, Inc. Pharmaceuticals: MajorHealth Technology Develops pharmaceutical products for the treatment of cancer | Corporate Officer/Principal | 01.12.2011 |
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
| Private Unternehmen | 4 |
|---|---|
Oncolytics Biotech, Inc.
Oncolytics Biotech, Inc. BiotechnologyHealth Technology Discovers and develops pharmaceutical products for the treatment of cancers | Health Technology |
The University of Texas at Austin
The University of Texas at Austin Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Janssen Oncology, Inc.
Janssen Oncology, Inc. Pharmaceuticals: MajorHealth Technology Develops pharmaceutical products for the treatment of cancer | Health Technology |
Puma Biotechnology, Inc.
Puma Biotechnology, Inc. Pharmaceuticals: MajorHealth Technology Operates as a development stage company which develops biopharmaceuticals used for the treatment of cancer | Health Technology |
Bitte wählen Sie Ihre Ausgabe
Alle länderspezifischen Finanzinformationen